Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
16.14
+0.24 (1.51%)
Jun 16, 2026, 10:12 AM EDT - Market open
Rallybio Market Cap
Rallybio has a market cap or net worth of $85.38 million as of June 16, 2026. Its market cap has increased by 563.98% in one year.
Market Cap
85.38M
Enterprise Value
37.46M
1-Year Change
563.98%
Ranking
Category
Stock Price
$16.14
Market Cap Chart
Since the IPO on July 29, 2021, Rallybio's market cap has decreased from $405.60M to $85.38M, a decrease of -78.95%. That is a compound annual growth rate of -27.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 85.38M | 194.58% |
| Dec 31, 2025 | 28.98M | -27.23% |
| Dec 31, 2024 | 39.83M | -55.91% |
| Dec 29, 2023 | 90.33M | -63.67% |
| Dec 30, 2022 | 248.60M | -18.90% |
| Dec 31, 2021 | 306.52M | -24.43% |
| Jul 29, 2021 | 405.60M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rein Therapeutics | 89.12M |
| PolyPid | 88.58M |
| ImmuCell | 87.57M |
| Aardvark Therapeutics | 85.08M |
| Biomea Fusion | 84.59M |
| Adicet Bio | 84.53M |
| Anixa Biosciences | 84.04M |
| NeurAxis | 82.98M |